Ex-CDC official discusses expected vaccine committee vote on Hep B shot for newborns

The first day of the CDC vaccine advisers meeting was marked by significant conflict and chaos as the panel discussed potential changes to the childhood vaccination schedule, including the hepatitis B vaccine for infants. This meeting follows a series of delays and contentious debates surrounding vaccination policies.

The CDC vaccine advisory group has postponed a planned vote on the hepatitis B vaccine for infants, originally scheduled for Thursday, to allow members additional time to review proposed changes to longstanding vaccination policies. This decision follows a contentious discussion among the advisers regarding the implications of altering the vaccination schedule for newborns.

The Centers for Disease Control and Prevention (CDC) is considering a significant change to its vaccination policy, potentially ending the routine administration of the hepatitis B vaccine to newborns within 24 hours of birth. This decision is expected to be voted on by a panel of advisers, reflecting a shift in the long-standing practice of vaccinating infants against this virus.

New research indicates that brief glitches during video calls can negatively impact how individuals are perceived by viewers, potentially leading to mistrust. These technical issues, often dismissed as minor inconveniences, may have more significant implications for personal and professional interactions.

Doctors are expressing concern over a potential change in the hepatitis B vaccination schedule for newborns, as RFK Jr.'s vaccine panel considers delaying the administration of the shot. This decision could lead to a resurgence of hepatitis B, a disease that has historically caused severe health issues and fatalities among unvaccinated infants.